Christopher Yasiejko
AbbVie sues Amgen to fend off copy of $4B Humira drug
WASHINGTON - Biotechnology drugmaker AbbVie Inc. filed a lawsuit seeking to block Amgen Inc. from selling a copy of the arthritis medicine Humira, its...









